We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARS icon
376
Tarsus Pharmaceuticals
TARS
$3.98B
$56.9K ﹤0.01%
904
-49
-5% -$3.13K
SUPN icon
377
Supernus Pharmaceuticals
SUPN
$2.53B
$56.6K ﹤0.01%
1,216
-72
-6% -$3.46K
GRAL
378
GRAIL Inc
GRAL
$3.59B
$56.5K ﹤0.01%
828
-48
-5% -$2.83K
CDP icon
379
COPT Defense Properties
CDP
$3.99B
$55.7K ﹤0.01%
1,532
-175
-10% -$5.69K
BNL icon
380
Broadstone Net Lease
BNL
$3.99B
$53.5K ﹤0.01%
2,589
-270
-9% -$5.45K
KRC icon
381
Kilroy Realty
KRC
$4.32B
$53.2K ﹤0.01%
1,421
-278
-16% -$9.45K
BCRX icon
382
BioCryst Pharmaceuticals
BCRX
$2.55B
$53.1K ﹤0.01%
5,306
+598
+13% +$5.41K
NRIX icon
383
Nurix Therapeutics
NRIX
$2.71B
$52.9K ﹤0.01%
2,180
-86
-4% -$1.47K
MBX
384
MBX Biosciences
MBX
$2.97B
$52.5K ﹤0.01%
952
-57
-6% -$1.99K
IRT icon
385
Independence Realty Trust
IRT
$3.79B
$52.4K ﹤0.01%
3,140
-395
-11% -$6.39K
LEGN icon
386
Legend Biotech
LEGN
$4.19B
$51.6K ﹤0.01%
1,788
-93
-5% -$2.51K
APLE icon
387
Apple Hospitality REIT
APLE
$3.68B
$51.1K ﹤0.01%
3,041
-363
-11% -$5.19K
TRVI icon
388
Trevi Therapeutics
TRVI
$2.46B
$50.7K ﹤0.01%
2,717
-148
-5% -$2.15K
KOD icon
389
Kodiak Sciences
KOD
$2.22B
$50.4K ﹤0.01%
1,294
+102
+9% +$3.97K
ABCL icon
390
AbCellera Biologics
ABCL
$3.7B
$50.4K ﹤0.01%
6,414
-282
-4% -$1.38K
SLG icon
391
SL Green Realty
SLG
$3.94B
$48.8K ﹤0.01%
942
-133
-12% -$5.93K
VCEL icon
392
Vericel Corp
VCEL
$2.06B
$48K ﹤0.01%
1,078
-58
-5% -$2.09K
AUPH icon
393
Aurinia Pharmaceuticals
AUPH
$2.14B
$47.8K ﹤0.01%
2,815
-132
-4% -$2.11K
NHI icon
394
National Health Investors
NHI
$3.48B
$47.7K ﹤0.01%
626
-92
-13% -$7.04K
PHVS icon
395
Pharvaris
PHVS
$2.47B
$47K ﹤0.01%
1,358
-81
-6% -$2.45K
AGIO icon
396
Agios Pharmaceuticals
AGIO
$1.98B
$46.1K ﹤0.01%
1,242
-68
-5% -$2.06K
OCUL icon
397
Ocular Therapeutix
OCUL
$2.34B
$45.2K ﹤0.01%
4,607
-177
-4% -$1.6K
MLYS icon
398
Mineralys Therapeutics
MLYS
$2.49B
$45.2K ﹤0.01%
1,676
-101
-6% -$2.77K
HIW icon
399
Highwoods Properties
HIW
$3.44B
$44.9K ﹤0.01%
1,488
-146
-9% -$3.78K
HRMY icon
400
Harmony Biosciences
HRMY
$2.46B
$44.7K ﹤0.01%
1,227
-67
-5% -$2.11K
14 15
16
17 18

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.